A detailed history of Alberta Investment Management Corp transactions in Neogenomics Inc stock. As of the latest transaction made, Alberta Investment Management Corp holds 74,734 shares of NEO stock, worth $1.23 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
74,734
Previous 106,041 29.52%
Holding current value
$1.23 Million
Previous $1.47 Million 25.03%
% of portfolio
0.01%
Previous 0.02%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024

SELL
$13.4 - $17.73 $419,513 - $555,073
-31,307 Reduced 29.52%
74,734 $1.1 Million
Q2 2024

Aug 13, 2024

BUY
$13.01 - $15.77 $232,423 - $281,731
17,865 Added 20.26%
106,041 $1.47 Million
Q1 2024

May 14, 2024

BUY
$14.06 - $16.79 $1.24 Million - $1.48 Million
88,176 New
88,176 $1.39 Million

Others Institutions Holding NEO

About NEOGENOMICS INC


  • Ticker NEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 125,796,000
  • Market Cap $2.07B
  • Description
  • NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...
More about NEO
Track This Portfolio

Track Alberta Investment Management Corp Portfolio

Follow Alberta Investment Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alberta Investment Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alberta Investment Management Corp with notifications on news.